Evidence map›Paper›PMID 32213610›Full record

ArticleJournal of virology2020

Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.

Allen Jankeel, Andrea R Menicucci, Courtney Woolsey, Karla A Fenton, Norma Mendoza, Krista Versteeg, Robert W Cross, Thomas W Geisbert, Ilhem Messaoudi

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.Recent advances in anti-infective drug discovery · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Allen Jankeel *Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, California, USA.
Andrea R Menicucci *Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, California, USA.
Courtney Woolsey *Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Karla A FentonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Norma MendozaDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, California, USA.
Krista VersteegDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Robert W CrossDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Thomas W GeisbertDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA twgeisbe@utmb.edu imessaou@uci.edu.
Ilhem MessaoudiDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, California, USA twgeisbe@utmb.edu imessaou@uci.edu.
The University of Texas Medical Branch at Galveston · USUniversity of California, Irvine · US

Funding

Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Gene Garrard Olinger · 2011 to 2026
$208.8M
Supplemental Research Project (SRP)U19AI109711 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GEISBERT, THOMAS WILLIAM · 2014 to 2018
$26.6M
Molecular mechanisms of immune dysregulation by filoviral interferon U19AI109945 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2014 to 2018
$9.5M
NIAID NIH HHS U19 AI109711NIAID NIH HHS U19 AI109945NIAID NIH HHS UC7 AI094660
6 · The paper itself

Abstract

Ebola virus (EBOV) continues to pose a significant threat to human health, as evidenced by the 2013-2016 epidemic in West Africa and the ongoing outbreak in the Democratic Republic of the Congo. EBOV causes hemorrhagic fever, organ damage, and shock culminating in death, with case fatality rates as high as 90%. This high lethality combined with the paucity of licensed medical countermeasures makes EBOV a critical human pathogen. Although EBOV infection results in significant damage to the liver and the adrenal glands, little is known about the molecular signatures of injury in these organs. Moreover, while changes in peripheral blood cells are becoming increasingly understood, the host responses within organs and lymphoid tissues remain poorly characterized. To address this knowledge gap, we tracked longitudinal transcriptional changes in tissues collected from EBOV-Makona-infected cynomolgus macaques. Following infection, both liver and adrenal glands exhibited significant and early downregulation of genes involved in metabolism, coagulation, hormone synthesis, and angiogenesis; upregulated genes were associated with inflammation. Analysis of lymphoid tissues showed early upregulation of genes that play a role in innate immunity and inflammation and downregulation of genes associated with cell cycle and adaptive immunity. Moreover, transient activation of innate immune responses and downregulation of humoral immune responses in lymphoid tissues were confirmed with flow cytometry. Together, these data suggest that the liver, adrenal gland, and lymphatic organs are important sites of EBOV infection and that dysregulating the function of these vital organs contributes to the development of Ebola virus disease.

Indexed as

Adrenal GlandsEbolavirusHemorrhagic Fever, EbolaLiverLymphoid TissueMonkey DiseasesAnimalsFemaleGene Expression Regulation, ViralMacaca fascicularisMaleTranscription, GeneticadrenalEbola virushemorrhagic feverliverlymph nodesNHPpathogenesisspleentissuestranscriptomics

Identifiers

PMID32213610
PMCPMC7269430
OpenAlexW3013386648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.